Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06176092 · ClinicalTrials.gov registry record

UCF Deciding Brains

A clinical trial of Trust, sponsored by University of Central Florida.

Recruiting
Registry status
400
Enrollment target
1
Study location

NCT06176092: Recruiting study of Trust, sponsored by University of Central Florida.

NCT06176092 is a study of Trust that is actively recruiting participants, run by University of Central Florida. The registered enrollment target is 400 participants, above the 132-participant average among 6 other Trust trials with a reported enrollment target (203% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06176092, a study of Trust, is actively recruiting participants, sponsored by University of Central Florida.

RECRUITING
Registry status
400 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research study is to understand how people make trust-related decisions in healthy aging. Participants will be asked to complete one study session on the University of Central Florida (UCF) campus. The study session will be conducted in a private testing room and include a series of computerized cognitive tasks and learning games, as well as surveys of your beliefs, preferences, and past experiences. The study will take a total of approximately 3.5 hours to completed. You will be allowed to take breaks during the session as needed. If you begin the study but do not complete the session, you will receive credit commensurate with your participation.

Primary Outcome

The NIH Toolbox which includes cognitive tasks to measure: Cognitive Function Composite Score, Fluid Cognition Composite Score, and Crystallized Cognition Composite Score

Conditions Studied

Study Locations (1)

Florida

  • University of Central Florida - Orlando

Trial Details

FieldValue
Enrollment Target 400 participants
Start Date 2023-09-21
Est. Completion 2029-06
University of Central Florida

91 total trials

What NCT06176092 shows while recruiting

NCT06176092 is an observational study that tracks outcomes without assigning an intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, above the 132-participant average among 6 other Trust trials with a reported enrollment target (203% higher).

The record links to 1 condition, with Trust appearing as the primary indexed condition, and to 0 interventions.

NCT06176092 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT06176092 about?

NCT06176092 is a clinical study titled "UCF Deciding Brains". The purpose of this research study is to understand how people make trust-related decisions in healthy aging. Participants will be asked to complete one study session on the University of Central Florida (UCF) campus. The study session will be conducted in a private testing room and include a serie...

What is the current status of trial NCT06176092?

This trial is currently recruiting. The enrollment target is 400 participants. The study started on 2023-09-21. Estimated completion is 2029-06.

What conditions does trial NCT06176092 study?

This clinical trial studies the following conditions: Trust.

Who is sponsoring clinical trial NCT06176092?

This trial is sponsored by University of Central Florida, which has 91 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06176092 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Trust

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01665326 · 400 participants

    Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease

  • NCT02108054 · 400 participants · NA

    Behavioral and Functional Task Development, Implementation, and Testing

  • NCT02216500 · 400 participants · NA

    Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy

  • NCT02250352 · 400 participants

    Core Biopsies for Establishing a Breast Tumor Tissue Repository

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06176092, the US trial registry maintained by the National Library of Medicine. NCT06176092 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.